| ALCL: ALK- | anaplastic large cell lymphoma, ALK-negative |
| ALCL, ALK+ | anaplastic large cell lymphoma, ALK-positive |
| B2M | beta-2 microglobulin |
| CR | complete remission |
| CT | computed tomography |
| EBER | Epstein-Barr virus-encoded RNA |
| EBV | Epstein-Barr virus |
| ECOG | Eastern Cooperative Oncology Group |
| ENKTL | extranodal NK/T-cell lymphoma, nasal type |
| FISH | fluorescence in situ hybridization |
| GI-TNKL | primary gastrointestinal T/NK cell lymphoma |
| HR | hazard ratio |
| IHC | immunohistochemical staining |
| IPI | international prognostic index |
| ITCL, NOS | intestinal T-cell lymphoma, NOS |
| LDH | lactate dehydrogenase |
| MALT | mucosa-associated lymphoid tissue |
| MEITL | monomorphic epitheliotropic intestinal T-cell lymphoma |
| OS | overall survival |
| PD | progressive disease |
| PFS | progression-free survival |
| PR | partial response |
| SD | stable disease |
| TCR | T-cell receptor |
| WHO | World Health Organization |